| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Precigen, Inc. (PGEN) has 13 insiders with recent SEC Form 4 filings, including 58 buys and 5 sells. PGEN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.77M | $20.28M | -119,250 | |
| Other | 755.5K | $4.06M | -29,131 | |
| Dir | 613.6K | $3.30M | - | |
| CFO | 554.5K | $2.98M | -41,884 | |
| COO | 497.8K | $2.68M | -42,703 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2019 | Sterling Rick L. | Chief Financial Officer | Sale+OE | 4,359 | $7.76 | $33,825.84 | -4.0% | |
| Jul 1, 2019 | Reed Thomas D. | Chief Science Officer | Sale+OE | 3,527 | $7.76 | $27,369.52 | -3.2% | |
| Jul 1, 2019 | Perez Jeffrey Thomas71 | SVP, Ip Affairs | Sale+OE | 4,359 | $7.76 | $33,825.84 | -9.3% | |
| Jul 1, 2019 | Lehr Donald P.75 | Chief Legal Officer | Sale+OE | 4,822 | $7.76 | $37,418.72 | -7.7% | |
| Jul 1, 2019 | Bostick Thomas | Chief Operating Officer | Sale+OE | 4,359 | $7.76 | $33,825.84 | -10.8% | |
| Jun 7, 2019 | Kirk Randal J | Chief Executive Officer | Buy | 483,268 | $5.24 | $2,534,162.29 | +1.0% | |
| Jun 7, 2019 | Kirk Randal J | Chief Executive Officer | Buy | 322,179 | $5.24 | $1,689,443.28 | +5.6% | |
| Jun 4, 2019 | Kirk Randal J | Chief Executive Officer | Buy | 135,548 | $4.91 | $665,516.24 | +2.5% | |
| Jun 4, 2019 | Kirk Randal J | Chief Executive Officer | Buy | 203,321 | $4.91 | $998,269.19 | +0.4% | |
| May 30, 2019 | Kirk Randal J | Chief Executive Officer | Buy | 330,180 | $4.75 | $1,567,799.00 | +7.0% |